Wells Fargo Downgrades Applied Genetic Technologies Corp. (AGTC) to Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/4/2026
- S&P 500, Dow hit record highs on strong AI-linked earnings, Mideast deal hopes
- Caterpillar stock jumps on strong earnings and revenue beat
- Optical component stocks rally on proposed U.S. ban on Chinese tech
- BofA says this memory stock could double. Here are 5 reasons why
- Merck shares rise on big Q2 earnings beat, adjusted FY outlook
- Nutanix to cut 5% of workforce, expects up to $43M in charges
- Palantir posts 93% revenue growth in Q2 2026, raises full-year outlook
- Grainger CFO resigns, interim replacement named
- Microsoft joins, Broadcom exits Goldman's top-stocks list
- Walmart dips after Oppenheimer downgrades shares on difficult short-term setup
- After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
- After-Hours Stock Movers: META, MSFT, CMG, SBUX, CVNA, LRCX, FTNT, QCOM, TDOC
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
BMO Capital Cuts Price Target on Applied Genetic Technologies (AGTC) to $20
September 13, 2016 8:18 AM EDTBMO Capital maintained an Outperform rating on Applied Genetic Technologies Corp. (NASDAQ: AGTC), and cut the price target to $20.00 (from $25.00), after updating estimates. BMO is now expecting data for XLRS in 2017 vs 2H16 previously as enrollment is slower-than-expected. The trial has enrolled 8/27 patients... More
Janney Montgomery Scott Downgrades Applied Genetic Technologies Corp. (AGTC) to Sell
September 13, 2016 7:17 AM EDTJanney Montgomery Scott downgraded Applied Genetic Technologies Corp. (NASDAQ: AGTC) from Buy to Sell with a price target of $11.00 (from $23.00).
For an analyst ratings summary and ratings history on Applied Genetic Technologies Corp.... More
Applied Genetic Technologies (AGTC) Tops Q4 EPS by 8c
September 12, 2016 4:23 PM EDTApplied Genetic Technologies (NASDAQ: AGTC) reported Q4 EPS of $0.15, $0.08 better than the analyst estimate of $0.07. Revenue for the quarter came in at $12.1 million versus the consensus estimate of $12.93 million.
For earnings history and earnings-related data on Applied Genetic Technologies (AGTC) click here.
... More